Thalidomide for recalcitrant discoid lesions in a patient with systemic lupus erythematosus

Journal of the American Academy of Dermatology

Volumn 39, Issue 2 I, 1998, Pages 293-295

  Warren, K J ^a   Nopper, A J ^a   Crosby, D L ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; DAPSONE; FLUOCINONIDE; PREDNISONE; THALIDOMIDE;

ADULT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CASE REPORT; DISCOID LUPUS ERYTHEMATOSUS; DISEASE COURSE; FEMALE; HUMAN; LUPUS ERYTHEMATOSUS; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SKIN BIOPSY; SKIN MANIFESTATION; SYSTEMIC LUPUS ERYTHEMATOSUS; TOPICAL DRUG ADMINISTRATION; TREATMENT OUTCOME;

EID: 0031869351     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0190-9622(98)70096-9     Document Type: Article

References (10)

1. C. Jaworsky Connective tissue diseases D Elder R Elenitas C Jaworsky B Johnson Lever’s Histopathology of the skin. 1997 Lippincott-Raven Philadelphia 253 285
2. J Barba-Rubio F. Franco-Gonzalez Lupus eritematoso discoide y talidomida Dermatol Rev Mex 19 1975 131 139
3. D Bessis B Guillot S Monpoint M Dandurand JJ. Guilhou Thalidomide for systemic lupus erythematosus Lancet 339 1992 549 550
4. E Atra EI. Sato Treatment of the cutaneous lesions of systemic erythematosus with thalidomide Clin Exp Rheumatol 11 1993 487 493
5. M Faure J Thivolet M. Gaucherand Inhibition of PMN leukocytes chemotaxis by thalidomide Arch Dermatol Res 269 1980 275 280
6. RL Barnhill NJ Doll LE Millikan RC. Hastings Studies on the anti-inflammatory properties of thalidomide: effects on polymorphonuclear leukocytes and monocytes J Am Acad Dermatol 11 1984 814 819
7. BE Turk H Jiang JO. Liu Binding of thalidomide to alpha1-acid glycoprotein may be involved in its inhibition of tumor necrosis factor alpha production Proc Natl Acad Sci U S A 93 1996 7552 7556
8. RJ Keenan G Eiras GJ Burckart RS Stuart RL Hardesty G Vogelsang Immunosuppressive properties of thalidomide: inhibition of in vitro lymphocyte proliferation alone and in combination with cyclosporine or FK506 Transplantation 52 1991 908 910
9. EJ Shannon RO Miranda MJ Morales RC. Hasting Inhibition of de novo IgM antibody synthesis as a relevant mechanism of action in leprosy Scand J Immunol 13 1981 553 562
10. R Neubert H Helge D. Neubert Thalidomide and the immune system: down regulation of the CD26 receptor, probably involved in the binding of HIV components to T cells in primates Life Sci 56 1995 407 420